LTI-03 was shown to reduce inflammation and scarring in lung tissue collected from IPF patients and analyzed in a lab, ...

For columnist Sam Kirton, Pulmonary Fibrosis Awareness Month is an opportunity to tell others about his journey.

Diabetes mellitus (DM) is a possible risk factor for post-COVID-19 pulmonary fibrosis (PCPF), according to meta-analysis study findings published in BMC Pulmonary Medicine.

Antifibrotic drugs like pirfenidone (Esbriet; Genentech) and nintedanib (Ofev; Boehringer Ingelheim) have been shown to be effective in patients with idiopathic pulmonary fibrosis (IPF) and in some ...

Patients with acute exacerbations of idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF) face a high risk of morbidity and mortality and require careful, expert management, ...

Idiopathic pulmonary fibrosis is a potentially fatal disease currently without treatment, in which lung tissue develops scarring and becomes stiff, making breathing increasingly difficult over time.

A research group from the National Cancer Research Center (CNIO) has found that an alteration in the POT1 gene prevents lung tissue from regenerating, which over time makes breathing difficult. The ...

Topline data were announced from a phase 3 trial evaluating efzofitimod in patients with pulmonary sarcoidosis.

Many people notice breathlessness now and then and quickly find reasons to explain it away, perhaps they are out of shape, ...